PMR Publications   |   PMR Consulting   |   PMR Research   |   PMR Online Access
 
 

Generics will continue their domination on the pharmaceutical market in Central and Eastern Europe until 2011 - November 2009

The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011. The growth rate of the innovative drug market, which was worth €12.4bn in 2008, will be slower, according to our latest report entitled “Generic and innovative drugs market in Central and Eastern Europe 2009. Comparative analysis, reimbursement policies and development forecasts for 2009-2011”.

To receive a full version of this FREE article, please fill in the form below. The article (in a PDF file article in pdf format) will be sent to your e-mail address.

None of this information will be disclosed to third parties.
To be assured that we take your privacy seriously, please read our Privacy Policy.

Please fill out all the fields correctly. Information will only be provided if forms are adequately completed.


Email:
In order to make sure you receive our information, please add our email address: info@pmrcorporate.com to the list of safe sources in your company. Please contact your IT department for details. Thank you.

Choose sector of interest: (You must specify at least one sector)

construction: retail: pharma: it & telecom: general economy:

Additional:
(specify)

Please read our Privacy Policy.


 

People who downloaded this free article, have read also:

More information on this topic in PMR product:

The main objective of the report is the description of the situation on generics and innovative drugs markets in eight Central and Eastern European countries: Poland, Russia, Ukraine, the Czech Republic, Slovakia, Hungary, Romania and Bulgaria. The report focuses on comparing analyzing policies of respective countries, as well as of the whole region, towards generic and innovative preparations used in medicine. The largest players and their strategies are presented as well as best selling drugs and important preparations which are to loose patent protection in coming years.
more »
 
About us         Contact us         Privacy Policy
Copyright © 2010 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.